Release Date: 24/02/11 08:50 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 200.08KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%